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Cartilage imaging: motivation, techniques,
current and future significance
Abstract Cartilage repair techniques
and pharmacological therapies are
currently areas of major clinical inter-
est and research, in particular to
prevent and treat osteoarthritis. MR
imaging-based techniques to visualize
cartilage are prerequisites to guide
and monitor these therapies. In this
review article, standard MR imaging
sequences are described, including
proton density-weighted fast spin
echo, spoiled gradient echo and dual
echo steady state sequences. In addi-
tion, new sequences that have been
developed and are currently being
investigated are presented, including
driven equilibrium Fourier transform
and steady-state free precession-based
imaging. Using high-field MR imag-
ing at 3.0-T, visualization of cartilage
and the related pathology has been
improved. Volumetric quantitative
cartilage MR imaging was developed
as a tool to monitor the progression of
osteoarthritis and to evaluate new
pharmacological cartilage protective
therapies. The most exciting develop-
ments, however, are in the field of
cartilage matrix assessment with
quantitative dGEMRIC, T2 and T1rho
mapping techniques. These techniques
aim at detecting cartilage damage at
a stage when changes are potentially
still reversible, before cartilage tissue
is lost. There is currently substantial
interest in these techniques from
rheumatologists and orthopedists;
radiologists therefore need to keep up
with these developments.
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Motivation to optimize cartilage imaging
Cartilage is one of the most important biomarkers in
degenerative and traumatic joint disease. MR imaging has
been established as the standard cartilage imaging modal-
ity, and techniques have been developed and optimized (1)
to visualize cartilage morphology, (2) to quantify its
volume and (3) to analyze its biochemical composition.
The substantial amount of research that is invested in the
development of these morphologic and quantitative imag-
ing techniques is motivated by new therapeutic modalities
both on a surgical (cartilage repair) and a pharmacological
level.
What therapies are available?
New surgical techniques that are available to treat focal
cartilage lesions include mosaicplasty, microfracture, dril-
ling procedures and autologous chondrocyte implantation
[1–3]. Mosaicplasty, also termed osteochondral autograft
transplantation (OAT) or autologous osteochondral trans-
plantation, is one of the most promising techniques that has
been developed [4–6]. This technique is used most fre-
quently at the knee and ankle joints, but has also been
advocated in other joints such as the elbow to treat focal
chondral or osteochondral defects due to injury, degener-
ation, osteochondritis dissecans or osteonecrosis. In the
T. M. Link (*) . R. Stahl
Department of Radiology,
University of California,
400 Parnassus Ave, A-367,





Institut für Röntgendiagnostik des
Klinikums rechts der Isar,
Technische Universität München,
München, Germany
microfracture technique, small perforations are created in
the subchondral bone plate after debridement of a cartilage
defect. Drilling procedures are applied in osteochondritis
dissecans if the cartilage surface is intact, but they are
frequently only successful if patients are skeletally imma-
ture [7]. Chondrocyte implantation has been performed
with autologous chondrocytes and allografts. The cartilage
defect is debrided and filled with a suspension of cultured
chondrocytes and covererd by a periosteal flap or chon-
drocyte-impregnated scaffolds [8]. The results are some-
what controversial [9, 10], with one study indicating that
cartilage repair tissue was of varying morphology ranging
from predominantly hyaline in 22% of biopsy specimens,
to mixed in 48%, and to predominantly fibrocartilage in
30% [10]. A recent study [11] comparing mosaicplasty and
autologous chondrocyte implantation showed that both
treatments resulted in a decrease in patient symptoms.
However, the improvement provided by the autologous
chondrocyte implantation lagged behind that provided by
mosaicplasty. Histologically, the defects treated with auto-
logous chondrocyte implantation were primarily filled with
fibrocartilage, whereas the osteochondral cylinder trans-
plants retained their hyaline character.
A number of pharmacological therapies have been
suggested to preserve cartilage or to treat cartilage damage.
These include (1) injectable therapies, such as corticoste-
roids and viscosupplementation that have elicited a
favorable short-term response, but no long-term structural
modification, and (2) slow-acting drugs, such as chondroi-
tin and glucosamine sulfate, which have shown promising
results [12]. Anti-inflammatory activity and the chondro-
protective action of chondroitin sulfate associated with
modifying cartilage structure have been found [13].
Pharmaceutical companies are currently investing force-
fully in developing cartilage protective agents, which will
be available in the near future. These are also driving the
research in developing MR-based biomarkers to assess
protective effects of their agents at the earliest possible
stage.
What are the indications for cartilage imaging?
The most important clinical indications for MR imaging are
the assessment of cartilage in osteoarthritis, chronic or
acute osteochondral injury, osteochondritis dissecans,
chondromalacia patellae, spontaneous osteonecrosis of
the femoral condyle (SONC or Ahlbaeck’s disease) and
inflammatory arthropathies (in particular before invasive
therapy). In addition, dedicated cartilage imaging is re-
quired after invasive cartilage repair procedures or con-
servative therapies, including pharmacological therapies, to
monitor the treatment’s effect. MR studies are required to
tailor therapies, and in the future, new quantitative tech-
niques may at some stage have significance in indicating
treatment as well as monitoring therapy similar to the
bone mineral density currently used in the setting of
osteoporosis.
What are the standard sequences to image cartilage?
Most experience and good results in imaging cartilage and
chondral pathology were gathered with (1) proton-density
(PD) and T2-weighted (w) fast spinecho (FSE) and (2) 3D
spoiled gradient echo (SPGR) or fast low-angle shot
(FLASH) sequences. Additional fat suppression in these
sequences was found useful to visualize cartilage pathology.
While 3D SPGR and FLASH sequences are well suited to
depict surface lesions, PD-w and T2-w FSE sequences also
show cartilage internal pathology because of the more
intermediate signal of the cartilage and higher intrinsic
cartilage contrast in these sequences (Fig. 1). Many
institutions, including those of the authors, tend to use
intermediate-w FSE sequences with a mixed PD/T2 contrast
(echo time =33–60 ms), which are thought to provide higher
intrinsic contrast and to be less prone to magic angle effects
as compared with “true” PD-w pulse sequences obtained at
short echo times. The bright signal in the SPGR and FLASH
images limits visualization of internal cartilage pathology to
Fig. 1 Chondromalacia patellae
in a 19-year-old male patient.
A fs intermediate-w FSE
(4,300/51 ms; TR/TE) (a) and a
fs T1-w SPGR (21/12.5 ms/15
degrees; TR/TE/flip angle)
(b) sequence were obtained in
an axial orientation at 3.0 T.
Cartilage defects and edema as
well as subchondral bone edema
are shown. Note that the inter-
mediate-w FSE sequence shows
increased signal of cartilage
clearly (arrow in a), while
SPGR sequence shows better
delineation of cartilage surface
(arrow in b)
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some extent, and fissures, for example, may sometimes be
not as well visualized (Fig. 2). A number of studies have
been performed comparing SPGR versus PD or T2-w FSE
sequences [14–16], and similar overall diagnostic perfor-
mance in detecting focal cartilage lesions has been found for
both sequence types. 3D SPGR and FLASH sequences
provide high spatial resolution; however, imaging time with
these sequences is usually fairly high, and image quality can
be degraded by motion artifacts. These gradient echo se-
quences are also very sensitive to susceptibility artifacts,
which should be considered after previous surgery, in
particular after cartilage repair procedures. In our clinical
practice, we found intermediate–w FSE sequences (the
acquisition time of high-resolution sequences was approxi-
mately 7–12 min) easier to use and more practically
applicable than SPGR or FLASH (acquisition time approxi-
mately 9–14 min) sequences. Bredella et al. [17] also found
these sequences to be accurate and fast for detecting and
grading articular cartilage defects in the knee. In their
experience, a combination of different planes improved the
sensitivity and specificity for chondral defects.
In addition to these sequences, the 3D double echo
steady state sequence (3D DESS) has also shown good
results in detecting cartilage lesions (Fig. 3). This mixed
T1/T2*-w sequence provides high spatial resolutions with
the cartilage appearing more intermediate in signal. In an
experimental study, Woertler et al. [18] found a similar
performance of fs 3D FLASH and water-excited 3D
double-echo steady state (DESS) sequences in detecting
cartilage surface lesions. Ruehm et al. analyzed patellar
cartilage abnormalities in 58 consecutive patients using a
3D-DESS without fat suppression and a T2-weighted FSE
sequence. These authors concluded that the DESS se-
quence was less accurate in detecting cartilage surface
abnormalities, yet more accurate in diagnosing cartilage
softening [19].
What field strength should be used to image cartilage?
This question is easily answered with regard to the
clinically available systems: the higher the field strength,
the better the diagnostic outcome. At present, standard
imaging is performed at 1.5 T, as 3-T systems are not yet
widely available. Low-field systems should not be used
for cartilage imaging as previous studies have shown that
low-field MR scanners operating at field strengths of
0.18–0.20 T [18, 20, 21] have substantial limitations
Fig. 2 Cartilage fissure (ar-
rows) in a 45-year-old female
imaged with a fs intermediate-w
FSE (4,300/51 ms) (a) and a fs
T1-w SPGR (21/12.5 ms/15
degrees) (b) sequence obtained
in a sagittal orientation. Note
that the fissure is clearly de-
picted with the intermediate-w
FSE image, while it is not as
well appreciated on the fs SPGR
image. Popliteal artery pulsation
artifacts are more pronounced
on the SPGR sequence
Fig. 3 DESS sequence (25.7/9 ms) with water excitation obtained
in a sagittal orientation at the ankle in a 30-year-old male with an
acute trauma. A cartilage fissure at the talus (arrow) and adjacent
bone marrow edema are visualized. Note that cartilage is interme-
diate in signal, while joint fluid is bright
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compared to high-field systems (1.5 T) in visualizing
cartilage pathology.
As previously mentioned, 3-T systems have shown
promise in optimizing cartilage imaging. The great appeal
of 3-T MR imaging for musculoskeletal MR is the
improvement in image quality and spatial resolution.
Because the signal-to-noise ratio (SNR) correlates in an
approximately linear fashion with field strength, it is
roughly twice as great at 3 T as at 1.5 T. The time necessary
to acquire satisfactory images can be substantially reduced,
minimizing motion artifacts and possibly speeding patient
turnover. Alternatively, the same acquisition time can be
used to obtain images at higher spatial resolution. Also,
greater contrast is available at higher field strength. All of
these features are particularly attractive for cartilage
imaging, in particular for smaller joints. However, acqui-
sition of imaging studies with a higher field machine
clearly mandates considerable adjustment of an MR
imaging practice, including revision of many imaging
protocols. We have to be aware of the fact that greater SNR
and contrast come at a price. First, tissues differ in their
magnetic susceptibility, and this effect is exacerbated at
higher field strengths. Second, there are safety concerns:
the energy deposited in the patient’s tissues is fourfold
higher at 3 T than at 1.5 T. Third, 3-T images are more
subject to flow artifacts, which may be a particular problem
in the knee joint. In addition there is doubling of the
chemical shift when the field strength is doubled. Imaging
parameters therefore have to be adjusted to the higher field
strength, which includes increasing TR and bandwidth as
well as decreasing TE and flip angles [22–24].
Previous in vitro studies showed that artificial defects
created in specimens were better visualized at 3 T than at
1.5 T [14, 15, 25]. Figure 4 shows representative images
obtained at 1.5 T (a) and at 3 T (b) with a fat saturated PD w
imaging sequence and identical acquisition times. Similar
results were also obtained in vivo [26]. Figure 5 shows
sagittal images of the knee joint in a subject with an
osteochondral lesion at the femoral condyle obtained with a
SPGR sequence obtained with the same acquisition time at
1.5 and 3 T. The differences in image quality and SNR are
clearly appreciated.
What new techniques are available to image cartilage?
A number of sequences have been developed to improve
morphological depiction of cartilage. These include driven
equilibrium Fourier transform (DEFT) and steady-state free
precision (SSFP) imaging.
DEFT imaging makes use of a much higher cartilage-to-
fluid contrast; the signal of synovial fluid is higher than in
SPGR sequences, and the signal of cartilage is higher than
in T2-ws FSE sequences [27]. Yoshioka et al. used this
sequence in 35 osteoarthritic knees and correlated the
imaging findings with arthroscopy; in their study, the fat-
suppressed three-dimensional DEFT images showed re-
sults similar to SPGR and PD-w FSE sequences with high
sensitivities yet relatively low specificities [16]. Gold et al.
compared 3D-DEFT and T2-FSE sequences in 104
consecutive patients with knee pain and used arthroscopy
in 24 patients as a standard of reference [28]. These
investigators found that the 3D-DEFT sequences provided
excellent synovial fluid-to-cartilage contrast while pre-
serving signal from cartilage, giving this method a high
cartilage SNR. In addition, 3D-DEFT showed the full
cartilage thickness better than T2-FSE, yet T2-FSE had
superior fat saturation and fewer artifacts than 3D-DEFT.
SSFP imaging has been described as an efficient, high-
signal method for obtaining 3D images and may be useful
to depict cartilage since cartilage signal was found to be
higher than in conventional sequences [29]. Kornaat et al.
used this sequence in volunteers at 1.5 and 3 T and found
that SSFP-based techniques showed a higher increase in
SNR and CNR efficiency at 3 T than SPGR sequences [26].
Figure 6 shows a representative image of a knee joint with
Fig. 4 Artificially created car-
tilage lesion at the patella
(arrows) in a pig knee imaged
with a fs intermediate-w FSE
at 1.5 T (a) and 3.0 T (b)
(4,000/35 ms). Note that the
lesion is substantially better
visualized at 3.0 T
1138
cartilage defects at the posterior medial femoral condyle
imaged with a non-fat saturated SSFP sequence. Bauer et
al. compared SSFP, PD-w FSE and SPGR sequences in
their performance in assessing cartilage lesions at cadaver
ankles and found the highest ROC (receiver-operator
characteristics) values for PD-w FSE sequences at 3.0 T,
yet FSE and SSFP sequences showed a similar perfor-
mance at 1.5 T, and both showed better results at 3.0 and
1.5 T than the SPGR sequence [22]. To our knowledge,
larger clinical studies, however, have not yet been
performed using this sequence. It should be noted that
the previously described DESS sequence is also a steady
state sequence and thus has cartilage signal features similar
to the SSFP sequences, yet the parameters are different to
some extent.
Direct MR arthrography with the use of T1-weighted
pulse sequences following the intraarticular injection of
gadolinium chelates has been shown to represent a reliable
imaging technique for the detection of surface lesions of
articular cartilage with sensitivities and specificities rang-
ing from 85 to 100% [30, 31]. The injected fluid produces
high contrast within the joint space, and at the same time
distends the joint, and thus improves the separation of
corresponding joint surfaces, such as the chondral surfaces
of the femur and the tibia. A simple method to produce
artificial arthrographic contrast in a T1-like FSE sequence
with the use of a driven equilibrium pulse (DRIVE) has
recently been described (Fig. 7). In contrast to the 3D
DEFT sequence mentioned above, this 2D technique
provides bright signal intensity of joint fluid with otherwise
unchanged signal intensities compared with a normal T1-w
FSE sequence at high spatial resolution and short scan
times [32]. Driven equilibrium pulses can also be used to
increase the contrast and/or spatial resolution of interme-
diate weighted FSE images (Fig. 8). However, this new
technique and its value for cartilage imaging are still under
clinical evaluation.
The role of cartilage volume
Quantitative MR imaging of cartilage is currently used in
ongoing studies to monitor cartilage volume and will be
used to assess structural effects of pharmacological
therapies on cartilage in order to prove their effectiveness
(Fig. 9). Although joint space narrowing on weight-bearing
radiographs still is the accepted surrogate marker for
demonstrating structural change by regulatory agencies,
this is expected to change in the near future, given the
Fig. 6 Sagittal MR image in a patient with osteoarthritis and
extensive cartilage lesions at the medial femoral condyle of the knee
joint (arrows). The image was obtained with a SSFP sequence
(5.5/1.9 ms/15 degrees) without fat saturation. Cartilage is interme-
diate to low in signal and fluid is bright; note large joint effusion and
baker cyst as well as osteophytes
Fig. 5 Osteochondral lesion in
a 32-year-old male with chronic
knee pain. Sagittal SPGR se-
quences obtained at 3.0 T
(21/12.5 ms/15 degrees) (b) and
at 1.5 T (30/16 ms/30 degrees)
(a) with similar acquisition
times. Note that image quality is
substantially improved at 3.0 T




inherent limitations of radiography. Considering the
tremendous cost involved to bring a drug to market and
the limited time during which a drug can be exclusively
marketed by the company who has developed it, it is
evident that a decrease in the study duration and/or study
participants involves huge economic savings for the
pharmaceutical industry, and this has stimulated high
interest in this novel technology. Quantitative MR imaging
of cartilage is also used in the Osteoarthritis Initiative
(OAI), a current program jointly sponsored by the National
Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS) of the National Institute of Health
(NIH) and the pharmaceutical industry targeted at iden-
Fig. 7 Native arthrographic ef-
fect of a driven equilibrium
pulse. Sagittal T1-weighted FSE
image (600/20 ms) (a) and
corresponding FSE image
(600/20 ms) with driven equi-
librium pulse (b) shows increase
of signal intensity of free
water resulting in bright signal
of joint fluid with otherwise
unchanged signal intensities
Fig. 8 High resolution intermediate weighted FSE image with
driven equilibrium pulse obtained at 1.5 T shows areas of increased
signal intensity (arrows) as well as superficial fissuring (arrowhead)
of patellar cartilage consistent with grade 1 (softening/swelling with
intact cartilage surface) and 2 (fissuring/blistering) articular cartilage
lesions
Fig. 9 Segmentation of femoral (•), tibial (▪), and patellar (▾)
cartilage on a sagittal SPGR image using a semi-automatic
technique based on Bezier-Splines and edge-detection. Bone-
cartilage interface: white line: articular surface: black line
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tifying the most promising OA biomarkers for analyzing
the development and progression of symptomatic knee
osteoarthritis involving a cohort of 5,000 participants that
will be imaged for a period of 5 years. Also, a number of
clinical, longitudinal studies found that quantitative MR
imaging could measure the progression of knee OA pre-
cisely and help to identify patients with rapidly progressing
disease [33–35].
Considerable effort has been spent on optimizing car-
tilage volume measurements to serve as potential outcome
markers in pharmaceutical trials. The MR sequences that
have been almost exclusively used for cartilage morphol-
ogy quantification are thin section fs T1-wSPGR or
FLASH sequences. With these images, cartilage displays
higher signal in comparison with adjacent tissues (bone and
joint fluid), facilitating segmentation of the cartilage
(Fig. 9). Several semi-automated techniques have been
described to optimize cartilage segmentation, including
active shape models, edge detection, fitting B-splines to
manually segmented points and B-spline snake (active
contours) [36–38], but to date, most large-scale studies
have relied on manual segmentation.
Eckstein et al. found long-term precision errors that
ranged from 1.4% (total knee) to 3.9% (total femur) for
cartilage volume and thickness [39], making this technique
attractive for longitudinal studies. It was also shown that
noninvasive quantitative MR imaging-based analysis of
cartilage morphometry is accurate and precise in severe OA
and displays high potential diagnostic value [40]. Quan-
titative analysis of OA by MR imaging using T and Z
scores for cartilage volume has been proposed [41].
However, cartilage volume should be normalized to the
individual joint surface area in order to maximize the
discriminatory power of this technique for the diagnosis of
OA.
A recent study found that quantitative MR imaging
measurements of cartilage at 3.0 T tended to be more
reproducible than at 1.5 T and thus may provide a superior
ability to detect changes in cartilage status over time and to
determine responses to treatment with structure-modifying
drugs [42]. Moreover, Bauer et al. found in an vitro study
that measurements of cartilage volume at 3.0 T were more
accurate than those obtained at 1.5 T [43].
What are the surrogate measures of cartilage
composition?
In the last years, significant interest focused on imaging
cartilage composition as a potential early marker for
degenerative joint disease. Cartilage consists of approxi-
mately 70% water, and the remainder predominantly of
type II collagen fibers and glycosaminglycans (GAG).
These GAG macromolecules contain negative charges that
attract sodium ions (NA+). One of the most common MR
contrast agents, gadopentetate dimeglumine (Gd-DTPA2-;
Magnevist®, Schering, Berlin, Germany), has a negative
charge and will therefore show a lower concentration in
cartilage areas of high GAG concentrations following
penetration via diffusion. In fact, it will be distributed in
higher concentrations in areas with lower GAG concen-
tration and thus pathologic cartilage composition. Ga-
dopentetate dimeglumine concentrations in cartilage can be
quantified, and this technique has been defined as
dGEMRIC or delayed gadolinium-enhanced MR imaging
of cartilage. Initial studies have shown that the dGEMRIC
measurement of GAG corresponds to the true GAG
concentration as measured with biochemistry and histology
[44, 45]. This technique has also been used in a number of
clinical studies, and variations of this measurement have
been shown in patients with osteoarthritis, trials of
autologous chondrocyte implants and subjects with seden-
tary lifestyles versus those with regular exercise [46–49].
Williams et al. examined 31 patients with knee OA using
Fig. 10 Sagittal MR images of
a 50-year-old female with early
osteoarthritis. In (a) a fs inter-
mediate-w FSE (4,300/51 ms)
sequence shows bone marrow
edema at the inferior part of the
patella (arrow), the overlying
cartilage shows subtle signal
increase and inhomogeneity. In
the contrast-enhanced T1-w
dGEMRIC image (b) obtained
90-min post-injection increased
contrast uptake is shown in
the area overlying the area of
bone marrow edema (arrow)
indicating cartilage damage with
loss of GAG
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MR imaging with a dGEMRIC protocol at 1.5 T as well as
semiflexed-knee and full-limb radiographs to assess align-
ment [49]. These authors found that compartments of the
knee joint without joint space narrowing had a higher
dGEMRIC index than those with any level of narrowing
(mean: 408 ms versus 365 ms; P=0.001). In knees with one
unnarrowed (spared) and one narrowed (diseased) com-
partment, the dGEMRIC index was greater in the spared
versus the diseased compartment (mean: 395 ms versus
369 ms; P=0.001). In spared compartments, there was a
trend toward a lower dGEMRIC index with increasing
radiographic severity of osteoarthritis. Valgus-aligned
knees tended to have lower dGEMRIC values laterally,
and varus-aligned knees tended to have lower dGEMRIC
values medially. The authors concluded that these quanti-
tative findings may have a particularly important role in
evaluating early osteoarthritis. Figure 10 shows images of a
patient with early osteoarthritis and patellar cartilage
damage as visualized by increased Gd-DTPA uptake in
the dGEMRIC study, which is not as well visualized on a
standard intermediate-w FSE sequence.
The results of an experimental study with a human
patella specimen suggest that delayed imaging can also be
useful to diagnose early articular cartilage damage
following intraarticular contrast administration (direct
MR arthrography) (Fig. 11) [50]. With histopathologic
assessment as the standard of reference, delayed T1-
weighted MR images allowed the detection of grade 1
(softening/swelling with intact cartilage surface) and 2
(fissuring/blistering) cartilage lesions in 94% of the cases,
although the pattern of contrast accumulation within
damaged cartilage was somewhat different from that
expected from the results of the studies mentioned above.
The authors concluded that, at least in cartilage lesions that
histologically can already be classified as grade 1 or 2,
contrast kinetics might, in addition to the GAG concentra-
tion, also be influenced by alterations of the collagen and
water content as well as the integrity of the cartilage
surface. First results of experimental studies with selec-
tively proteoglycan and collagen depleted cartilage support
this theory and indicate that delayed gadolium-enhanced
MR imaging might not allow the differentiation of GAG
and collagen loss [51].
Another approach that has been used to measure
cartilage composition is T2 mapping (Fig. 12). It was
shown that the increasing T2 relaxation time was
proportional to the distribution of cartilage water and is
sensitive to small water content changes [52]. In an early
study, Dardzinski et al. examined the spatial variation of in
vivo cartilage T2 in young asymptomatic adults and found
a reproducible pattern of increasing T2 that was propor-
tional to the known spatial variation in cartilage water and
was inversely proportional to the distribution of proteogly-
cans [53]. These authors postulated that the regional T2
differences were secondary to the restricted mobility of
cartilage water within an anisotropic solid matrix. Thus,
measurement of the spatial distribution of the T2 reflecting
areas of increased and decreased water content may be used
to quantify cartilage degeneration before morphologic
changes are appreciated.
In a preliminary study, Mosher et al. showed that aging is
associated with an asymptomatic increase in T2 of the
transitional zone of articular cartilage. The results of their
study indicated that this diffuse increase in T2 in senescent
cartilage is different in appearance than the focally
increased T2 observed in damaged articular cartilage
[54]. In an additional study, Mosher et al. obtained T2
maps at 3.0 T of the weight-bearing femoral and tibial
articular cartilage in seven young healthy men before and
immediately after 30 min of running [55]. They found no
statistically significant change in T2 profiles of tibial
cartilage, but a statistically significant decrease in T2 of the
superficial 40% of weight-bearing femoral cartilage after
exercise. These data support the hypothesis that cartilage
compression results in greater anisotropy of superficial
collagen fibers. Dunn et al. analyzed 55 subjects who were
categorized with radiography as healthy (n=7) or as having
mild OA (n=20) or severe OA (n=28) [56]. These authors
found that healthy subjects had mean T2 values of 32.1–
35.0 ms, while patients with mild and severe OA had mean
T2 values of 34.4–41.0 ms. All cartilage compartments
except the lateral tibia showed significant (P<0.05)
increases in T2 relaxation time between healthy and
diseased knees. The correlation of T2 values with clinical
Fig. 11 Delayed transverse fat-suppressed T1-w images obtained
after direct MR arthrography show increased contrast uptake of
articular cartilage at the lateral facet of the patella (arrowhead).
Arthroscopy (not shown) verified cartilage softening and the
integrity of the cartilage surface consistent with a grade 1 articular
cartilage lesion
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symptoms and cartilage morphology was found predomi-
nantly in medial compartments.
A different parameter that has been proposed to measure
cartilage composition is 3D-T1rho-relaxation mapping
(Fig. 12). T1rho describes the spin-lattice relaxation in
the rotating frame, and changes in the extracellular matrix
of cartilage, like the loss of GAG, may be reflected in
measurements of T1rho due to less restricted motion of
water protons. Preliminary results demonstrated the in vivo
feasibility of quantifying early biochemical changes in
symptomatic osteoarthritis subjects employing T1rho-
weighted MR imaging on a 1.5-T clinical scanner [57,
58]. In a study with a limited number of symptomatic
subjects, it was shown that T1rho-weighted MRI provided
a noninvasive marker for quantitation of early degenerative
changes of cartilage in vivo [57]. Li et al. examined ten
healthy volunteers and nine osteoarthritis patients at 3T and
found a significant difference (P=0.002) in the average
T1rho within patellar and femoral cartilage between con-
trols (45.04±2.59 ms) and osteoarthritis patients (53.06±
4.60 ms) [59]. A significant correlation was found between
T1rho and T2 relaxation measurements; however, the dif-
ference of T2 was not significant between controls and
osteoarthritis patients. These initial results suggested that
T1rho relaxation times may be a promising clinical tool for
osteoarthritis detection and treatment monitoring. Further
studies are clearly mandated to correlate T1rho measure-
ments with early osteoarthritis determined from arthrosco-
py, as a standard of reference, in larger symptomatic
populations [57].
Fig. 12 Color-coded T2 (a, b) and T1rho (c, d) maps overlaid on a
sagittal SPGR image in a 35-year-old male before (a, c) and after
(b, d) a marathon. After the marathon (b), T2 times were
significantly increased, mainly in the patella and the trochlea
(from 14.4±15.01 ms to 35.2±7.71 ms), indicating cartilage edema
with increased water content secondary to the physical stress. The
patella, femur and lateral tibia plateau showed only a small increase
in T1rho times after the marathon (d), indicating only a subtle
change in cartilage macromolecular matrix
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A future technique to assess the structural properties of
cartilage may be diffusion tensor imaging (DTI). DTI
determines, in addition to T2 and T1rho mapping, not only
the degree, but also the main direction of the free mobility
of water protons. The findings from Filidoro et al. [60] on
patella specimens at 9.4 T suggest that the DTI-derived
parameter fractional anisotropy (FA) and eigenvector maps
might reflect the macromolecular environment (like GAG
concentration) and the predominant alignment of the
collagenous fiber network, respectively. However, further
studies are required to establish DTI at clinical high-field-
strength systems for the use in human subjects.
Summary and conclusion
Recent new therapeutic modalities, in particular in osteo-
arthritis, have made cartilage MR imaging an exciting field
of clinical interest and research. Cartilage imaging is a
challenge, but new techniques provide better morphologic
visualization and quantification as well as insights in the
cartilage composition. It should be noted that currently
morphologic imaging to depict cartilage lesions is standard
for the clinical routine, and a number of cartilage dedicated
sequences are available for this purpose. These, however,
show damage at stages when cartilage is irreversibly lost.
The future goal of MR imaging will be to diagnose
cartilage matrix changes at stages when damage to the
cartilage is still reversible and may be treated. This is an
ambitious goal, yet promising tools, such as dGEMRIC,
T1-rho and T2-relaxation time mapping are already
available, and future research will show how clinically
feasible these new biomarkers are as measures of early
cartilage degeneration. Together with new pharmacological
therapies, this may revolutionize management of osteoar-
thritis and could have a tremendous impact on population
health. There is a huge interest in these MR techniques
from other subspecialties, including rheumatologists and
orthopedists; we as radiologists have to work hard to stay
on top of this and keep up to date with the new
developments.
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